On May 22, 2025, Aptevo Therapeutics Inc. received a notice from Nasdaq about not meeting the minimum stockholders’ equity requirement, reporting a deficit of $1,473,000, and it plans to submit a compliance plan by July 7, 2025. Additionally, the company announced a 1-for-20 reverse stock split effective May 23, 2025.